NDAORALCAPSULE
Approved
Dec 1991
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Lorabid (loracarbef) is an oral second-generation cephalosporin antibiotic approved in 1991 for bacterial infections including otitis media, respiratory tract infections, and urinary tract infections. It is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis. The drug is administered as an oral capsule and is primarily used for community-acquired infections in ambulatory settings.
LOE Approaching
With LOE approaching and competitive pressure at 30%, the brand team is likely in defensive mode with minimal headcount expansion and focus on margin protection rather than growth.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Lorabid offers limited career growth potential given its LOE-approaching status and mature market position with zero linked job openings. Roles on this product are primarily defensive, focused on maintaining market share, managing generic competition, and optimizing profitability rather than driving innovation or team expansion.
Brand ManagerField Sales Representative
Worked on LORABID at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.